指南与共识消化内镜

AGA快速综述与指南:疫苗接种后SARS-CoV2检测与内镜2021更新

AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update.
指南 / 共识 · Gastroenterology · 2021-05-21

美国胃肠病学会(AGA)基于GRADE框架更新疫苗接种后内镜前SARS-CoV2常规检测的建议,证据确定性极低,有条件推荐反对常规检测,高度重视减少患者诊疗延迟及检测负担。

要点

  • 基于极低确定性证据,有条件推荐反对内镜前常规SARS-CoV2检测。
  • 推荐重视减少患者诊疗延迟、内镜量下降及对癌症诊断的 downstream 影响。
  • 更新替代AGA 2020年7月29日发布的先前指南。

核心结论

  • 基于极低确定性证据,有条件推荐反对对计划接受内镜的患者进行常规内镜前SARS-CoV2检测。

研究设计与样本

  • AGA指南小组采用GRADE框架,审查无症状SARS-CoV2感染患病率、患者和医护人员感染风险、疫苗有效性、焦虑、诊疗延迟与癌症负担及内镜量等证据。

主要发现

  • 小组审查了内镜前无症状SARS-CoV2感染患病率、患者和医护人员在内镜前后感染风险、COVID-19疫苗降低感染和传播的有效性、患者和医护人员焦虑、患者诊疗延迟及对癌症负担的潜在影响、内镜量等证据。

关键数值与推荐

  • 基于极低确定性证据,有条件推荐反对常规内镜前SARS-CoV2检测。

临床怎么用

  • 临床实践中不应对计划接受内镜的患者常规进行内镜前SARS-CoV2检测。

局限性

  • 推荐基于极低确定性证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This guideline provides updated recommendations on the role of preprocedure testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in individuals undergoing endoscopy in the post-vaccination period and replaces the prior guideline from the American Gastroenterological Association (AGA) (released July 29, 2020). Since the start of the pandemic, our increased understanding of transmission has facilitated the implementation of practices to promote patient and health care worker (HCW) safety. Simultaneously, there has been increasing recognition of the potential harm associated with delays in patient care, as well as inefficiency of endoscopy units. With widespread vaccination of HCWs and the general population, a re-evaluation of AGA's prior recommendations was warranted. In order to update the role of preprocedure testing for SARS-CoV2, the AGA guideline panel reviewed the evidence on prevalence of asymptomatic SARS-CoV2 infections in individuals undergoing endoscopy; patient and HCW risk of infections that may be acquired immediately before, during, or after endoscopy; effectiveness of COVID-19 vaccine in reducing risk of infections and transmission; patient and HCW anxiety; patient delays in care and potential impact on cancer burden; and endoscopy volumes. The panel considered the certainty of the evidence, weighed the benefits and harms of routine preprocedure testing, and considered burden, equity, and cost using the Grading of Recommendations Assessment, Development and Evaluation framework. Based on very low certainty evidence, the panel made a conditional recommendation against routine preprocedure testing for SARS-CoV2 in patients scheduled to undergo endoscopy. The panel placed a high value on minimizing additional delays in patient care, acknowledging the reduced endoscopy volumes, downstream impact on delayed cancer diagnoses, and burden of testing on patients.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Sultan S, Siddique SM, Singh S, et al. AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update. Gastroenterology. 2021. PMID: 34029569. doi:10.1053/j.gastro.2021.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。